secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001493152-24-004806
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity receives Nasdaq delisting determination for failure to meet MVLS requirement; intends to appeal
--------------------------------------------------------------------------------

- Received delisting letter on Jan 30, 2024, for not regaining compliance with $35M MVLS requirement by Jan 29, 2024.
- Trading suspension on Nasdaq Capital Market set for Feb 8, 2024, unless the company appeals.
- Company plans to request a hearing before the Nasdaq Hearings Panel to appeal and present a compliance plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224004806/0001493152-24-004806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224004806/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer